A sirna targeting inhbe gene expression, conjugates, and uses thereof

TW202637840APending Publication Date: 2026-09-16LEADERNA THERAPEUTICS LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
TW114148152
Authority / Receiving Office
TW · TW
Patent Type
Applications
Current Assignee / Owner
Priority Date
2025-10-09
Filing Date
2025-12-09
Publication Date
2026-09-16

Smart Images

  • Figure TWG2TA001076681_001
    Figure TWG2TA001076681_001
  • Figure TWG2TA001076681_002
    Figure TWG2TA001076681_002
Patent Text Reader

Abstract

nucleotides in length and is at least partially complementary to the antisense strand. The siRNA, siRNA conjugates, and pharmaceutical compositions provided in the present invention exhibit favorable stability, excellent INHBE gene inhibition activity, satisfactory cytotoxicity, and immunostimulatory properties.
Need to check novelty before this filing date? Find Prior Art